Cargando…

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

BACKGROUND: Cuproptosis, a newly discovered form of cell death, is regulated by protein lipoylation and is related to mitochondrial metabolism. However, further research is needed to determine how the cuproptosis-related gene ferredoxin 1 (FDX1) affects the tumor immune response and its prognostic s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tao, Liu, Yufeng, Li, Qing, Luo, Yang, Liu, Dawei, Li, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549781/ https://www.ncbi.nlm.nih.gov/pubmed/36225932 http://dx.doi.org/10.3389/fimmu.2022.999823

Ejemplares similares

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
por: Xu, Jiahao, et al.
Publicado: (2022)

FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Zhong, Guanghui, et al.
Publicado: (2022)

Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma
por: Zeng, Song, et al.
Publicado: (2022)

A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Kenan, et al.
Publicado: (2022)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment
por: Xie, Mingyue, et al.
Publicado: (2022)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023)

Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting
por: Cai, Congbo, et al.
Publicado: (2023)

Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
por: Wu, Jiajin, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
por: Huang, Xing, et al.
Publicado: (2022)

The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
por: Yuan, Huiyang, et al.
Publicado: (2022)

Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
por: Fu, Liangmin, et al.
Publicado: (2022)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)
por: Wang, Lizong, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer
por: Wang, Jinyan, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma
por: Lu, Caibao, et al.
Publicado: (2022)

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
por: Liu, Gang, et al.
Publicado: (2023)

The role of cuproptosis-related gene in the classification and prognosis of melanoma
por: Liu, Jin-Ya, et al.
Publicado: (2022)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2022)

Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
por: Luo, Gang, et al.
Publicado: (2023)

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
por: Lin, Enyu, et al.
Publicado: (2022)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
por: Zhu, HuaXin, et al.
Publicado: (2022)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022)

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2022)

A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients
por: Zhang, Wei-Tong, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis
por: Nong, Jiao, et al.
Publicado: (2023)

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
por: Zhang, Ganghua, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma
por: Shen, Yefeng, et al.
Publicado: (2023)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma
por: Liu, Xianglong, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2023)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
por: Jin, Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4i2qp8p2mpu47r8hoodsdtas7d